Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06869122Recruiting

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates - UK

Role: lead

NCT06476678Recruiting

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

Role: collaborator

NCT05786625Active Not Recruiting

Bronchoscopic Microwave Ablation of Lung Tissue

Role: lead

NCT06689488Recruiting

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

Role: lead

NCT04406116Not ApplicableUnknown

Clinical Evaluation of the Safety and Performance of Microwave Coagulation Using the HS1 Instrument

Role: lead

NCT02372552Not ApplicableCompleted

Microwave Coagulation Using CROMA Electrosurgical System

Role: lead

All 6 trials loaded